Michael Lisman - 04 Nov 2025 Form 4 Insider Report for TransDigm Group INC (TDG)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Nov 2025, 16:32:08 UTC
Prior SEC filing
20 Nov 2024
Next SEC filing
17 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rachel L. Quinlan as attorney in fact for Michael Lisman

Key filing fact

Michael Lisman filed Form 4 for TransDigm Group INC (TDG) on 06 Nov 2025.

Key facts

  • This page summarizes Michael Lisman's Form 4 filing for TransDigm Group INC (TDG).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 06 Nov 2025, 16:32.

Change

  • Previous filing in this sequence was filed on 20 Nov 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001748275 Primary reporting owner

Lisman Michael

Relationship
President & CEO
Address
1350 EUCLID AVENUE, SUITE 1600, CLEVELAND
Signature
/s/ Rachel L. Quinlan as attorney in fact for Michael Lisman
Signature date
06 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDG transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+75,696
Change %
Price
$0.000000
Shares after
75,696
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
75,696
Exercise price
$1291.97
Footnotes
F1
TDG transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+3,907
Change %
Price
$0.000000
Shares after
3,907
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,907
Exercise price
$1291.97
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These options are exercisable at 20% per year over five years beginning September 30, 2026 subject to the achievement of annual operating performance targets in each year

Footnote F2

These options are exercisable at 80% in 2026 and 20% in 2027 subject to achievement of annual operating performance targets each year.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .